AGWCA
TECH icon

Annis Gardner Whiting Capital Advisors’s Bio-Techne TECH Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,299
Closed -$67.9K – 1150
2026
Q1 		$67.9K Buy
1,299
+97
+8% +$5.82K 0.01% 526
2025
Q4 		$70.7K Sell
1,202
-276
-19% -$16.8K 0.01% 466
2025
Q3 		$82.2K Buy
1,478
+1,182
+399% +$63.3K 0.02% 419
2025
Q2 		$15.2K Buy
+296
New +$14.9K 0.01% 617
2025
Q1 		– Sell
-53
Closed -$3.82K – 818
2024
Q4 		$3.82K Buy
53
+17
+47% +$1.25K ﹤0.01% 637
2024
Q3 		$2.88K Buy
36
+24
+200% +$1.8K ﹤0.01% 686
2024
Q2 		$860 Sell
12
-144
-92% -$10.6K ﹤0.01% 900
2024
Q1 		$11K Buy
+156
New +$11.2K ﹤0.01% 654

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's TECH Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 1,299 shares — an estimated $67.9K sold.

Annis Gardner Whiting Capital Advisors first reported a position in TECH in Q1 2024 and held it in 8 quarters. The position peaked at $82.2K in Q3 2025. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 1,299 Bio-Techne shares in Q2 2026, an estimated $67.9K.
  • Annis Gardner Whiting Capital Advisors first reported a position in Bio-Techne in Q1 2024 and held it in 8 quarters.
  • Annis Gardner Whiting Capital Advisors's Bio-Techne position peaked at $82.2K in Q3 2025.
  • 597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.